The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy.
about
18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start.The new era of cancer immunotherapy: what can molecular imaging do to help?PET and SPECT imaging of melanoma: the state of the art.Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community.Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab.Integrative analysis of imaging and transcriptomic data of the immune landscape associated with tumor metabolism in lung adenocarcinoma: Clinical and prognostic implications.Adaptive metabolic pattern biomarker for disease monitoring and staging of lung cancer with liquid biopsy
P2860
Q38638500-C8F8FF31-0725-4462-B4CC-2E0C28A19403Q47308572-1E76D184-1925-4113-9612-7161FB65EFACQ47868574-DCB1E911-1ABE-4C98-B084-B0CAF2C018B5Q48105701-DB8DDEC9-47F0-4A3B-A3F4-6F353DDF55C3Q48227716-8F6D83AE-818A-432E-BEA1-B1100459ACF6Q48329175-1C98595C-7164-462B-959D-66441B5091ECQ54997338-68C0BFAF-581B-4865-95DC-21352C45C0E9Q58795963-C161CC28-FC54-4B46-823D-A7192A652F6D
P2860
The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The Advantages and Challenges ...... eted Agents and Immunotherapy.
@en
The Advantages and Challenges ...... eted Agents and Immunotherapy.
@nl
type
label
The Advantages and Challenges ...... eted Agents and Immunotherapy.
@en
The Advantages and Challenges ...... eted Agents and Immunotherapy.
@nl
prefLabel
The Advantages and Challenges ...... eted Agents and Immunotherapy.
@en
The Advantages and Challenges ...... eted Agents and Immunotherapy.
@nl
P2860
P1476
The Advantages and Challenges ...... eted Agents and Immunotherapy.
@en
P2093
Annie N M Wong
Michael S Hofman
P2860
P2888
P356
10.1007/S00259-017-3691-7
P433
P577
2017-04-07T00:00:00Z